Arnaud joined Eurazeo as Managing Director of Eurazeo in March 2021. Arnaud spent most of his career in the healthcare industry, in M&A functions and as a CFO. He started working at Societe Générale in M&A, and subsequently joined Novartis, first in the Corporate M&A team based in Switzerland, and afterwards in the French affiliates as a CFO. In recent years, Arnaud was a freelance consultant advising healthcare start-ups. Throughout his career, Arnaud was exposed to various segments of the healthcare industry, such as vaccines and diagnostics, pharmaceuticals (innovative and generic medicine, OTC) and e-health.
Arnaud holds a master in finance from Université Paris Dauphine.